FDA: Hepatitis C Drugs Can Reactivate Hepatitis B
The FDA said that in a few cases, HBV reactivation resulted in serious liver problems or death. It said hepatitis C drugs could reactivate HBV within four to eight weeks.
As a result, the FDA said it is requiring black box warnings on hepatitis C DAAs about the risk...
To view the full article, register now.